APA (7th ed.) Citation

Li, J., Feng, T., Yang, W., Xu, Y., Wang, S., Cai, H., . . . Zhang, J. (2021). Rational formulation engineering of fraxinellone utilizing 6-O-α-D-maltosyl-β-cyclodextrin for enhanced oral bioavailability and hepatic fibrosis therapy. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Li, Jianbo, Tiange Feng, Weijing Yang, Yaru Xu, Shuaishuai Wang, Huijie Cai, Zhilei Liu, Hong Qiang, and Jinjie Zhang. Rational Formulation Engineering of Fraxinellone Utilizing 6-O-α-D-maltosyl-β-cyclodextrin for Enhanced Oral Bioavailability and Hepatic Fibrosis Therapy. Taylor & Francis Group, 2021.

MLA (8th ed.) Citation

Li, Jianbo, et al. Rational Formulation Engineering of Fraxinellone Utilizing 6-O-α-D-maltosyl-β-cyclodextrin for Enhanced Oral Bioavailability and Hepatic Fibrosis Therapy. Taylor & Francis Group, 2021.